KELLY MERCADO: Open Payments
NPI 1013266808 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,253 in 92 payments from 17 companies in 2025. Trend: 2023 $2,184 · 2024 $2,525 · 2025 $2,253
Food & beverage: $2,142Education: $111
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $732 |
| ABBVIE INC. | 16 | $375 |
| GENZYME CORPORATION | 10 | $202 |
| Phathom Pharmaceuticals, Inc. | 18 | $171 |
| Novo Nordisk Inc | 2 | $149 |
| Ipsen Biopharmaceuticals, Inc | 2 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Celltrion USA Inc. | 2 | $52 |
Products named: TREMFYA, RINVOQ, DUPIXENT, VOQUEZNA, Wegovy, IQIRVO, SKYRIZI, XIFAXAN.
Industry payments across MD — which companies pay providers there.
